{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T10:13:01Z","timestamp":1776852781551,"version":"3.51.2"},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T00:00:00Z","timestamp":1698364800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004895","name":"European Social Fund","doi-asserted-by":"publisher","award":["2019 FI B 00986"],"award-info":[{"award-number":["2019 FI B 00986"]}],"id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004895","name":"European Social Fund","doi-asserted-by":"publisher","award":["RYC2020-029886-I\/AEI\/10.13039\/501100011033"],"award-info":[{"award-number":["RYC2020-029886-I\/AEI\/10.13039\/501100011033"]}],"id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008551","name":"Fondation M\u00e9rieux","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008551","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ministry of Science and Innovation, Spain","award":["PID2019-110810RB-I00\/AEI\/10.13039\/501100011033"],"award-info":[{"award-number":["PID2019-110810RB-I00\/AEI\/10.13039\/501100011033"]}]},{"DOI":"10.13039\/100005624","name":"PATH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005624","id-type":"DOI","asserted-by":"publisher"}]},{"name":"GlaxoSmithKline Biologicals S.A","award":["NCT00197041"],"award-info":[{"award-number":["NCT00197041"]}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Centro de Investiga\u00e7\u00e3o em Sa\u00fade de Manhi\u00e7a"},{"DOI":"10.13039\/501100004892","name":"Agencia Espa\u00f1ola de Cooperaci\u00f3n Internacional para el Desarrollo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004892","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004892","name":"Spanish Agency for International Cooperation and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004892","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Spanish Ministry of Science and Innovation","doi-asserted-by":"publisher","award":["CEX2018-000806-S"],"award-info":[{"award-number":["CEX2018-000806-S"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008054","name":"Fundaci\u00f3n Ram\u00f3n Areces","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,3,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The RTS,S\/AS02A malaria vaccine is based on the Plasmodium falciparum circumsporozoite protein (PfCSP), which is O-fucosylated on the sporozoite surface. We determined whether RTS,S\/AS02A-induced immunoglobulin G (IgG) antibodies recognize vaccine-like nonfucosylated PfCSP better than native-like fucosylated PfCSP. Similar to previous vaccine trials, RTS,S\/AS02A vaccination induced high anti-PfCSP IgG levels associated with malaria protection. IgG recognition of nonfucosylated and fucosylated PfCSP was equivalent, suggesting that PfCSP fucosylation does not affect antibody recognition.<\/jats:p>\n               <jats:p>Clinical Trials Registration.\u2003NCT00197041.<\/jats:p>","DOI":"10.1093\/infdis\/jiad471","type":"journal-article","created":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T21:08:38Z","timestamp":1698354518000},"page":"795-799","source":"Crossref","is-referenced-by-count":1,"title":["RTS,S\/AS02A Malaria Vaccine-Induced IgG Responses Equally Recognize Native-Like Fucosylated and Nonfucosylated <i>Plasmodium falciparum<\/i> Circumsporozoite Proteins"],"prefix":"10.1093","volume":"229","author":[{"given":"Chenjerai","family":"Jairoce","sequence":"first","affiliation":[{"name":"Barcelona Institute for Global Health (ISGlobal), Hospital Cl\u00ednic-Universitat de Barcelona , Barcelona, Catalonia ,","place":["Spain"]},{"name":"Centro de Investiga\u00e7\u00e3o em Sa\u00fade de Manhi\u00e7a , Maputo ,","place":["Mozambique"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D\u00eddac","family":"Maci\u00e0","sequence":"additional","affiliation":[{"name":"Barcelona Institute for Global Health (ISGlobal), Hospital Cl\u00ednic-Universitat de Barcelona , Barcelona, Catalonia ,","place":["Spain"]},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Infecciosas (CIBERINFEC) , Barcelona ,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge P","family":"Torres-Yaguana","sequence":"additional","affiliation":[{"name":"Barcelona Institute for Global Health (ISGlobal), Hospital Cl\u00ednic-Universitat de Barcelona , Barcelona, Catalonia ,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonie","family":"Mayer","sequence":"additional","affiliation":[{"name":"Barcelona Institute for Global Health (ISGlobal), Hospital Cl\u00ednic-Universitat de Barcelona , Barcelona, Catalonia ,","place":["Spain"]},{"name":"Universit\u00e9 Claude Bernard Lyon 1, Universit\u00e9 de Lyon , Villeurbanne ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Vidal","sequence":"additional","affiliation":[{"name":"Barcelona Institute for Global Health (ISGlobal), Hospital Cl\u00ednic-Universitat de Barcelona , Barcelona, Catalonia ,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebeca","family":"Santano","sequence":"additional","affiliation":[{"name":"Barcelona Institute for Global Health (ISGlobal), Hospital Cl\u00ednic-Universitat de Barcelona , Barcelona, Catalonia ,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ram\u00f3n","family":"Hurtado-Guerrero","sequence":"additional","affiliation":[{"name":"Institute of Biocomputation and Physics of Complex Systems, University of Zaragoza , Zaragoza ,","place":["Spain"]},{"name":"Copenhagen Center for Glycomics, Department of Cellular and Molecular Medicine, University of Copenhagen , Copenhagen ,","place":["Denmark"]},{"name":"Fundaci\u00f3n Agencia Aragonesa para la Investigaci\u00f3n y el Desarrollo , Zaragoza ,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karine","family":"Reiter","sequence":"additional","affiliation":[{"name":"Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health , Bethesda, Maryland ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David L","family":"Narum","sequence":"additional","affiliation":[{"name":"Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health , Bethesda, Maryland ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Borja","family":"Lopez-Gutierrez","sequence":"additional","affiliation":[{"name":"Emerging Pathogens Institute, Department of Infectious Diseases and Immunology, College of Veterinary Medicine, University of Florida , Gainesville, Florida ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy","family":"Hamerly","sequence":"additional","affiliation":[{"name":"Emerging Pathogens Institute, Department of Infectious Diseases and Immunology, College of Veterinary Medicine, University of Florida , Gainesville, Florida ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jahit","family":"Sacarlal","sequence":"additional","affiliation":[{"name":"Centro de Investiga\u00e7\u00e3o em Sa\u00fade de Manhi\u00e7a , Maputo ,","place":["Mozambique"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth","family":"Aguilar","sequence":"additional","affiliation":[{"name":"Barcelona Institute for Global Health (ISGlobal), Hospital Cl\u00ednic-Universitat de Barcelona , Barcelona, Catalonia ,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rhoel R","family":"Dinglasan","sequence":"additional","affiliation":[{"name":"Emerging Pathogens Institute, Department of Infectious Diseases and Immunology, College of Veterinary Medicine, University of Florida , Gainesville, Florida ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gemma","family":"Moncunill","sequence":"additional","affiliation":[{"name":"Barcelona Institute for Global Health (ISGlobal), Hospital Cl\u00ednic-Universitat de Barcelona , Barcelona, Catalonia ,","place":["Spain"]},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Infecciosas (CIBERINFEC) , Barcelona ,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Izquierdo","sequence":"additional","affiliation":[{"name":"Barcelona Institute for Global Health (ISGlobal), Hospital Cl\u00ednic-Universitat de Barcelona , Barcelona, Catalonia ,","place":["Spain"]},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Infecciosas (CIBERINFEC) , Barcelona ,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6751-4060","authenticated-orcid":false,"given":"Carlota","family":"Doba\u00f1o","sequence":"additional","affiliation":[{"name":"Barcelona Institute for Global Health (ISGlobal), Hospital Cl\u00ednic-Universitat de Barcelona , Barcelona, Catalonia ,","place":["Spain"]},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Infecciosas (CIBERINFEC) , Barcelona ,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,10,27]]},"reference":[{"key":"2024102109042972800_jiad471-B1","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1056\/NEJMoa1102287","article-title":"First results of phase 3 trial of RTS,S\/AS01 malaria vaccine in African children","volume":"365","author":"RTS,S Clinical Trials Partnership","year":"2011","journal-title":"N Engl J Med"},{"key":"2024102109042972800_jiad471-B2","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1056\/NEJMoa1208394","article-title":"A phase 3 trial of RTS,S\/AS01 malaria vaccine in African infants","volume":"367","author":"RTS,S Clinical Trials Partnership","year":"2012","journal-title":"N Engl J Med"},{"key":"2024102109042972800_jiad471-B3","doi-asserted-by":"crossref","first-page":"609","DOI":"10.2217\/fmb-2017-0284","article-title":"Implications of Plasmodium glycosylation on vaccine efficacy and design.","volume":"13","author":"Goddard-Borger","year":"2018","journal-title":"Future Microbiol"},{"key":"2024102109042972800_jiad471-B4","doi-asserted-by":"crossref","first-page":"7425","DOI":"10.1016\/j.vaccine.2015.09.061","article-title":"RTS,S: toward a first landmark on the malaria vaccine technology roadmap","volume":"33","author":"Kaslow","year":"2015","journal-title":"Vaccine"},{"key":"2024102109042972800_jiad471-B5","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1038\/s41467-019-10195-z","article-title":"Concentration and avidity of antibodies to different circumsporozoite epitopes correlate with RTS,S\/AS01E malaria vaccine efficacy","volume":"10","author":"Doba\u00f1o","year":"2019","journal-title":"Nat Commun"},{"key":"2024102109042972800_jiad471-B6","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.sbi.2018.12.005","article-title":"Protein O-fucosylation: structure and function","volume":"56","author":"Holdener","year":"2019","journal-title":"Curr Opin Struct Biol"},{"key":"2024102109042972800_jiad471-B7","doi-asserted-by":"crossref","first-page":"e1005606","DOI":"10.1371\/journal.ppat.1005606","article-title":"Interrogating the Plasmodium sporozoite surface: identification of surface-exposed proteins and demonstration of glycosylation on CSP and TRAP by mass spectrometry-based proteomics.","volume":"12","author":"Swearingen","year":"2016","journal-title":"PLoS Pathog"},{"key":"2024102109042972800_jiad471-B8","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/s41467-017-00571-y","article-title":"Protein O-fucosylation in Plasmodium falciparum ensures efficient infection of mosquito and vertebrate hosts","volume":"8","author":"Lopaticki","year":"2017","journal-title":"Nat Commun"},{"key":"2024102109042972800_jiad471-B9","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/S0140-6736(04)17223-1","article-title":"Efficacy of the RTS,S\/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial","volume":"364","author":"Alonso","year":"2004","journal-title":"Lancet"},{"key":"2024102109042972800_jiad471-B10","doi-asserted-by":"crossref","first-page":"e0199278","DOI":"10.1371\/journal.pone.0199278","article-title":"Analysis of factors affecting the variability of a quantitative suspension bead array assay measuring IgG to multiple Plasmodium antigens","volume":"13","author":"Ubillos","year":"2018","journal-title":"PLoS One"},{"key":"2024102109042972800_jiad471-B11","doi-asserted-by":"crossref","first-page":"6059","DOI":"10.1016\/j.vaccine.2011.03.041","article-title":"Four year immunogenicity of the RTS,S\/AS02 A malaria vaccine in Mozambican children during a phase IIb trial","volume":"29","author":"Aide","year":"2011","journal-title":"Vaccine"},{"key":"2024102109042972800_jiad471-B12","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1016\/S1473-3099(15)00239-X","article-title":"Immunogenicity of the RTS,S\/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial","volume":"15","author":"White","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"2024102109042972800_jiad471-B13","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1146\/annurev-biophys-060414-034156","article-title":"Structure and immune recognition of the HIV glycan shield","volume":"47","author":"Crispin","year":"2018","journal-title":"Annu Rev Biophys"},{"key":"2024102109042972800_jiad471-B14","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12929-020-00669-4","article-title":"Hepatitis C virus vaccine design: focus on the humoral immune response","volume":"27","author":"Sepulveda-Crespo","year":"2020","journal-title":"J Biomed Sci"},{"key":"2024102109042972800_jiad471-B15","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1128\/IAI.02676-14","article-title":"Reversible conformational change in the Plasmodium falciparum circumsporozoite protein masks its adhesion domains","volume":"83","author":"Herrera","year":"2015","journal-title":"Infect Immun"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiad471\/53058521\/jiad471.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/229\/3\/795\/59923652\/jiad471.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/229\/3\/795\/59923652\/jiad471.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T09:05:45Z","timestamp":1729501545000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/229\/3\/795\/7331061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,27]]},"references-count":15,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,10,27]]},"published-print":{"date-parts":[[2024,3,14]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiad471","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,3,15]]},"published":{"date-parts":[[2023,10,27]]}}}